PL1888636T5 - Sposób oczyszczania przeciwciał - Google Patents
Sposób oczyszczania przeciwciałInfo
- Publication number
- PL1888636T5 PL1888636T5 PL06753791.0T PL06753791T PL1888636T5 PL 1888636 T5 PL1888636 T5 PL 1888636T5 PL 06753791 T PL06753791 T PL 06753791T PL 1888636 T5 PL1888636 T5 PL 1888636T5
- Authority
- PL
- Poland
- Prior art keywords
- purification
- ion exchange
- antibodies
- immunoglobulin
- single step
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
- B01D15/36—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction
- B01D15/361—Ion-exchange
- B01D15/362—Cation-exchange
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
- B01D15/36—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction
- B01D15/361—Ion-exchange
- B01D15/363—Anion-exchange
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/42—Selective adsorption, e.g. chromatography characterised by the development mode, e.g. by displacement or by elution
- B01D15/424—Elution mode
- B01D15/426—Specific type of solvent
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
- C07K1/18—Ion-exchange chromatography
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
- C07K16/065—Purification, fragmentation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2866—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/32—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against translation products of oncogenes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/96—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation using ion-exchange
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Physics & Mathematics (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP05011302 | 2005-05-25 | ||
PCT/EP2006/004863 WO2006125599A2 (en) | 2005-05-25 | 2006-05-23 | Method for the purification of antibodies |
EP06753791.0A EP1888636B2 (en) | 2005-05-25 | 2006-05-23 | Method for the purification of antibodies |
Publications (2)
Publication Number | Publication Date |
---|---|
PL1888636T3 PL1888636T3 (pl) | 2012-02-29 |
PL1888636T5 true PL1888636T5 (pl) | 2023-03-06 |
Family
ID=34936911
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL06753791.0T PL1888636T5 (pl) | 2005-05-25 | 2006-05-23 | Sposób oczyszczania przeciwciał |
Country Status (18)
Country | Link |
---|---|
US (3) | US20090098660A1 (pl) |
EP (2) | EP1888636B2 (pl) |
JP (1) | JP4852602B2 (pl) |
KR (1) | KR100967778B1 (pl) |
CN (1) | CN101180317B (pl) |
AT (1) | ATE525087T1 (pl) |
AU (1) | AU2006251307B2 (pl) |
BR (1) | BRPI0610201B8 (pl) |
CA (1) | CA2607375C (pl) |
DK (1) | DK1888636T4 (pl) |
ES (2) | ES2373402T5 (pl) |
FI (1) | FI1888636T4 (pl) |
IL (2) | IL186338A (pl) |
MX (1) | MX2007014269A (pl) |
NO (1) | NO345362B1 (pl) |
PL (1) | PL1888636T5 (pl) |
TW (2) | TWI391399B (pl) |
WO (1) | WO2006125599A2 (pl) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI391399B (zh) | 2005-05-25 | 2013-04-01 | Hoffmann La Roche | 測定溶離多肽之鹽濃度之方法 |
BRPI0812288A2 (pt) | 2007-06-01 | 2014-11-25 | Hoffmann La Roche | Purificação de imunoglobulina. |
CL2008002053A1 (es) * | 2007-07-17 | 2009-05-22 | Hoffmann La Roche | Metodo para la purificacion de una eritropoyetina monopeguilada (epompeg) que consiste en proporcionar una solucion que contiene eritropoyetina mono, poli y no peguilada y hacerla pasar por dos pasos de cromatografia de intercambio cationico y metodo para producir epo mpeg que incluye metodo de purificacion. |
CL2008002054A1 (es) | 2007-07-17 | 2009-05-29 | Hoffmann La Roche | Metodo para la regeneracion de una columna de cromatografia de intercambio cationico despues de la elusion de eritropoyetina monopeguilada y metodo para obtener una eritropoyetina monopeguilada, incorporando el metodo de regeneracion de la columna de intercambio cationico. |
MX2011001696A (es) * | 2008-08-14 | 2011-03-25 | Merck Sharp & Dohme | Metodos para purificar anticuerpos usando cromatografia de afinidad con proteina a. |
US9884904B2 (en) | 2010-03-10 | 2018-02-06 | Hoffmann-La Roche Inc. | Method for purifying polypeptide solutions |
CA2792717A1 (en) * | 2010-04-14 | 2011-10-20 | F. Hoffmann-La Roche Ag | Immunoglobulin aggregate removal |
RU2610667C2 (ru) * | 2010-10-11 | 2017-02-14 | Эббви Бахамаз Лтд., | Способ очистки белков |
MX357821B (es) | 2010-12-21 | 2018-07-25 | Hoffmann La Roche | Preparación de anticuerpo enriquecida con isoforma y método para obtenerla. |
PL3318571T3 (pl) | 2011-03-16 | 2021-07-05 | F. Hoffmann-La Roche Ag | Chromatografia jonowymienna o ulepszonej selektywności do rozdzielania monomerów, agregatów i fragmentów polipeptydowych przez modulację fazy ruchomej |
SG10201605397PA (en) | 2011-07-01 | 2016-08-30 | Hoffmann La Roche | Method For Separation Of Monomeric Polypeptides From Aggregated Polypeptides |
US10481164B2 (en) * | 2012-03-26 | 2019-11-19 | Amgen Inc. | Method for using light scattering in real time to directly monitor and control impurity removal in purification processes |
CN105555795A (zh) * | 2013-09-17 | 2016-05-04 | 株式会社钟化 | 新抗体纯化方法和由该方法得到的抗体、以及使用了阳离子交换基团的新抗体纯化法和由该方法得到的抗体 |
WO2015064971A1 (ko) * | 2013-10-30 | 2015-05-07 | (주)셀트리온 | 양이온 교환 크로마토그래피를 이용한 항체의 아형 분리 방법 |
CN107108720A (zh) | 2014-11-06 | 2017-08-29 | 豪夫迈·罗氏有限公司 | 具有改变的FCRN结合的Fc区变体及其使用方法 |
GB2539420B (en) * | 2015-06-16 | 2021-01-13 | Cytiva Sweden Ab | Determination of chromatography conditions |
RU2018121657A (ru) * | 2015-11-18 | 2019-12-19 | Мерк Патент Гмбх | ПРОТИВОПОЛОЖНЫЕ ГРАДИЕНТЫ pH-СОЛЬ ДЛЯ УЛУЧШЕННОГО РАЗДЕЛЕНИЯ БЕЛКОВ |
RU2018121653A (ru) * | 2015-11-18 | 2019-12-19 | Мерк Патент Гмбх | Улучшенное разделение белков при ионообменной хроматографии |
US11155575B2 (en) | 2018-03-21 | 2021-10-26 | Waters Technologies Corporation | Non-antibody high-affinity-based sample preparation, sorbent, devices and methods |
KR20200138346A (ko) * | 2018-04-03 | 2020-12-09 | 메르크 파텐트 게엠베하 | Cex 크로마토그래피 매질 및 생물제약 공급물로부터의 표적 단백질의 저염 용출 |
CN111068361B (zh) * | 2018-10-22 | 2022-02-11 | 中国石油化工股份有限公司 | 一种己内酰胺离子交换装置及其再生方法 |
CN110066314B (zh) * | 2019-04-01 | 2023-10-27 | 上海药明生物技术有限公司 | 一种高效提高多聚体分离分辨率的亲和纯化工艺 |
TW202128264A (zh) * | 2019-09-25 | 2021-08-01 | 瑞士商赫孚孟拉羅股份公司 | 使用經預測之溶離緩衝鹽濃度的陽離子層析法 |
Family Cites Families (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4136094A (en) * | 1977-08-31 | 1979-01-23 | The Regents Of The University Of Minnesota | Preparation of intravenous human and animal gamma globulins and isolation of albumin |
JPS5598117A (en) * | 1979-01-17 | 1980-07-25 | Chemo Sero Therapeut Res Inst | Purification of gamma-globulin derivative |
DE3271181D1 (en) * | 1982-02-08 | 1986-06-19 | Schweiz Serum & Impfinst | Intravenously administrable human immunoglobuline and process for its preparation |
JPS6042336A (ja) * | 1983-08-18 | 1985-03-06 | Nippon Seiyaku Kk | 免疫グロブリンの製造方法 |
DE3640513A1 (de) | 1986-11-27 | 1988-06-09 | Biotest Pharma Gmbh | Verfahren zur herstellung eines virussicheren, lagerstabilen und intravenoes vertraeglichen immunglobulin-g-praeparates |
US5118796A (en) * | 1987-12-09 | 1992-06-02 | Centocor, Incorporated | Efficient large-scale purification of immunoglobulins and derivatives |
US4983722A (en) | 1988-06-08 | 1991-01-08 | Miles Inc. | Removal of protein A from antibody preparations |
US5177194A (en) | 1990-02-01 | 1993-01-05 | Baxter International, Inc. | Process for purifying immune serum globulins |
EP0447585B2 (de) * | 1990-03-22 | 2003-05-07 | Biotest Pharma Gmbh | Verfahren zur Herstellung eines intravenös verträglichen Immunglobulin-G-Präparates |
JP3200850B2 (ja) * | 1991-02-26 | 2001-08-20 | 味の素株式会社 | ヒトbcdfの精製法 |
CA2108451A1 (en) | 1991-04-26 | 1992-10-27 | Beverley J. Randle | Novel antibodies, and methods for their use |
DE4118912C1 (pl) | 1991-06-08 | 1992-07-02 | Biotest Pharma Gmbh, 6072 Dreieich, De | |
ES2193136T3 (es) | 1991-08-14 | 2003-11-01 | Genentech Inc | Variantes de inmunoglubina para receptores especificos de fc epsilon. |
HUT68624A (en) | 1992-06-26 | 1995-07-28 | Aetsrn | Human monoclonal anti-rhesus (d) antibodies and cell lines producing same |
FR2706466B1 (fr) * | 1993-06-14 | 1995-08-25 | Aetsrn | Concentré d'immunoglobulines G à usage thérapeutique et procédé de production dudit concentré. |
IT1271461B (it) | 1993-12-01 | 1997-05-28 | Menarini Ricerche Sud Spa | Anticorpo monoclonale bispecifico anti-cd3/anti-egfr,processo per la produzione e suo uso. |
DE59309332D1 (de) | 1993-12-27 | 1999-03-04 | Rotkreuzstiftung Zentratrallab | Verfahren zur Herstellung eines Konzentrates von Anti-D-Immunoglobulin G und pharmazeutische Zusammensetzung, die dieses enthält |
US5429746A (en) † | 1994-02-22 | 1995-07-04 | Smith Kline Beecham Corporation | Antibody purification |
FI952196A0 (fi) * | 1995-05-08 | 1995-05-08 | Suomen Punainen Risti Veripalv | Framstaellning av immunoglobulin |
IL121900A (en) | 1997-10-07 | 2001-12-23 | Omrix Biopharmaceuticals Ltd | A method for the purification of immunoglobulins |
UA64742C2 (uk) | 1997-12-24 | 2004-03-15 | Альфа Терапевтик Корпорейшн | СПОСІБ ОДЕРЖАННЯ РОЗЧИНУ <font face="Symbol">g</font>-ГЛОБУЛІНУ, ПРИЗНАЧЕНОГО ДЛЯ ВНУТРІШНЬОВЕННОГО ВВЕДЕННЯ, І ПРОДУКТ, ЩО ОДЕРЖУЄТЬСЯ У ЦЕЙ СПОСІБ (ВАРІАНТИ) |
US6162904A (en) * | 1997-12-24 | 2000-12-19 | Alpha Therapeutic Corporation | Manufacturing method for intraveneously administrable immune globulin and resultant product |
CN103641885A (zh) † | 1998-05-06 | 2014-03-19 | 基因技术股份有限公司 | 用离子交换层析纯化蛋白质 |
DK1084136T3 (da) | 1998-06-01 | 2005-01-03 | Genentech Inc | Adskillelse af monomere af et antistof fra dets multimere ved anvendelse af ionbytterchromatografi |
DK2272870T3 (da) * | 1998-06-09 | 2013-08-05 | Csl Behring Ag | Fremgangsmåde til fremstilling af immunoglobuliner med henblik på intravenøs indgivelse og andre immunoglobulin-lignende produkter. |
ATE277950T1 (de) | 1998-06-09 | 2004-10-15 | Statens Seruminstitut | Verfahren zur herstellung von immunoglobulinen zur intravenösen verabreichung und anderen immunoglobulin-produkten |
US6441144B1 (en) * | 1999-05-20 | 2002-08-27 | Alpha Therapeutic Corporation | Method for repairing dual virally inactivated immune globulin for intravenous administration |
AU2001249574A1 (en) † | 2000-03-29 | 2001-10-08 | Ecokasa Incorporated | Nitrogen reduction wastewater treatment system |
SE0001128D0 (sv) | 2000-03-30 | 2000-03-30 | Amersham Pharm Biotech Ab | A method of producing IgG |
US6962700B1 (en) * | 2000-09-13 | 2005-11-08 | Atopix Pharmaceuticals Corporation | Method of manufacturing immune globulin |
EP1501369B1 (en) * | 2002-04-26 | 2015-06-24 | Genentech, Inc. | Non-affinity purification of proteins |
DK2332996T3 (en) | 2002-09-11 | 2014-12-15 | Genentech Inc | Purification of anti-Her2 antibodies |
CN1490334A (zh) * | 2002-10-18 | 2004-04-21 | 缪金明 | 基因特异性抗体的亲和纯化方法 |
AU2004215653B2 (en) | 2003-02-28 | 2011-03-17 | Lonza Biologics Plc. | Antibody purification by protein A and ion exchange chromatography |
AR045614A1 (es) | 2003-09-10 | 2005-11-02 | Hoffmann La Roche | Anticuerpos contra el recepctor de la interleuquina- 1 y los usos de los mismos |
BRPI0510883B8 (pt) * | 2004-06-01 | 2021-05-25 | Genentech Inc | composto conjugado de droga e anticorpo, composição farmacêutica, método de fabricação de composto conjugado de droga e anticorpo e usos de uma formulação, de um conjugado de droga e anticorpo e um agente quimioterapêutico e de uma combinação |
TWI391399B (zh) | 2005-05-25 | 2013-04-01 | Hoffmann La Roche | 測定溶離多肽之鹽濃度之方法 |
-
2006
- 2006-05-19 TW TW098127045A patent/TWI391399B/zh active
- 2006-05-19 TW TW095118030A patent/TWI320788B/zh active
- 2006-05-23 EP EP06753791.0A patent/EP1888636B2/en active Active
- 2006-05-23 FI FIEP06753791.0T patent/FI1888636T4/fi active
- 2006-05-23 AU AU2006251307A patent/AU2006251307B2/en active Active
- 2006-05-23 JP JP2008512752A patent/JP4852602B2/ja active Active
- 2006-05-23 MX MX2007014269A patent/MX2007014269A/es active IP Right Grant
- 2006-05-23 US US11/920,288 patent/US20090098660A1/en not_active Abandoned
- 2006-05-23 ES ES06753791T patent/ES2373402T5/es active Active
- 2006-05-23 CN CN200680017966XA patent/CN101180317B/zh active Active
- 2006-05-23 WO PCT/EP2006/004863 patent/WO2006125599A2/en active Application Filing
- 2006-05-23 ES ES10175706T patent/ES2389641T5/es active Active
- 2006-05-23 PL PL06753791.0T patent/PL1888636T5/pl unknown
- 2006-05-23 CA CA2607375A patent/CA2607375C/en active Active
- 2006-05-23 EP EP10175706.0A patent/EP2261252B2/en active Active
- 2006-05-23 BR BRPI0610201A patent/BRPI0610201B8/pt active IP Right Grant
- 2006-05-23 AT AT06753791T patent/ATE525087T1/de active
- 2006-05-23 KR KR1020077027285A patent/KR100967778B1/ko active IP Right Grant
- 2006-05-23 DK DK06753791.0T patent/DK1888636T4/da active
-
2007
- 2007-10-07 IL IL186338A patent/IL186338A/en active IP Right Grant
- 2007-10-09 NO NO20075091A patent/NO345362B1/no unknown
-
2010
- 2010-07-14 IL IL206993A patent/IL206993A0/en active IP Right Grant
-
2014
- 2014-05-06 US US14/271,058 patent/US9631007B2/en active Active
-
2017
- 2017-03-14 US US15/458,368 patent/US11034754B2/en active Active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI1888636T4 (fi) | Vasta-aineiden puhdistusmenetelmä | |
WO2010048192A3 (en) | Viral inactivation during purification of antibodies | |
EP1568710A3 (en) | Antibody purification method | |
WO2003102132A3 (en) | Non-affinity purification of proteins | |
ATE363491T1 (de) | Reinigung von antikörpern durch protein a und ionenaustauschromatographie | |
WO2007075283A3 (en) | Polishing steps used in multi-step protein purification processes | |
EA201592192A1 (ru) | Способ очистки моноклональных антител | |
WO2011090719A3 (en) | Protein purification by ion exchange | |
WO2006113643A3 (en) | High affinity fully human monoclonal antibodies to interleukin-8 and epitopes for such antibodies | |
MX9707909A (es) | Purificacion de anticuerpos. | |
WO2005090403A3 (en) | Method and apparatus for antibody purification | |
WO2003059935A3 (en) | Methods for purifying protein | |
ATE473244T1 (de) | Festphase zur verwendung in einem verfahren zur reinigung von albuminkonjugaten | |
ATE384742T1 (de) | Verfahren zur reinigung von preproinsulin | |
EP1780537A4 (en) | PROTEOMANALYSIS PROCESS FOR PHOSPHORYLATED PROTEIN | |
DE602004023626D1 (de) | Trennung von polypeptiden mit einer racemisierten aminosäure | |
MX2021012251A (es) | Metodo para purificar un anticuerpo modificado en la region de fragmento cristalizable (fc). | |
ATE461199T1 (de) | Verfahren zur trennung und reinigung von hydrocodon durch präparative chromatographie | |
WO2006035060A3 (en) | Purification of a bulk of a factor vii polypeptide by fractionated elution from an anion-exchange material | |
DK1558622T3 (da) | Fremgangsmåde til oprensning af macrolider | |
KR20220079910A (ko) | 숙주-세포 단백질을 특성화하는 방법 | |
ATE449177T1 (de) | Staphylococcus epidermidis antigene | |
DE602004018674D1 (de) | Grosstechnisches verfahren zur abtrennung und aufreinigung von fentanyl durch präparative umkehrphasenchromatographie | |
ATE468343T1 (de) | Verfahren zur reinigung von tacrolimus | |
DE60305075D1 (de) | Isolierung von antisense-oligonukleotiden |